 |
|
|
|
 |
|
|
| Article 1 to 10 out of 30 concerning deCODE genetics
|
-
Largest academic-industry collaboration for drug discovery in depression and schizophrenia launched
(21 Jan 2010)
An international consortium of scientists, led by H. Lundbeck A/S and King's College London, has launched one of the largest ever research academic-industry collaboration projects to find new methods for the development of drugs for schizophrenia ...
-
Scientists present the largest-to-date genetic snapshot of Iceland 1000 years ago
(19 Jan 2009)
Scientists at deCODE genetics have completed the largest study of ancient DNA from a single population ever undertaken. Analyzing mitochondrial DNA, which is passed from mother to offspring, from 68 skeletal remains, the study provides a detailed ...
-
deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer
(15 Oct 2008)
Latest discoveries add to understanding of individual risk of basal cell carcinoma, and are integrated into the deCODEme™ personal genome analysis scan
Scientists at deCODE genetics reported the discovery of common versions of two single-letter variations in the human genome (SNPs) that confer risk of basal cell carcinoma (BCC). Unlike the four sets of SNPs previously found by deCODE to confer risk ...
-
A Smoking Gene: deCODE Shows How a Single Variant in the Sequence of the Genome Confers Nicotine Dependence
(09 Apr 2008)
Cigarette smoking is a major public health problem that contributes to millions of deaths around the world each year. While the health risks of smoking are well known, relatively little is known about why some people are particularly likely to get ...
-
deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
(04 Feb 2008)
Scientists from deCODE genetics report the discovery of two common, single-letter variants in the sequence of the human genome (SNPs) that regulate one of the principle motors of evolution. Versions of the two SNPs, located on chromosome 4p16, have ...
-
Not only lipids and inflammation: Insight into a new cause of heart attack and other vascular disease
(08 Jan 2008)
deCODE scientists report that the genetic variant on chromosome 9p21 that the company has linked to increased risk of heart attack is also associated with up to 70% increase in risk of abdominal aortic aneurysm (AAA) and intracranial aneurysm (IA). ...
-
deCODE Gene Discovery Points to New Approach for Treating Major Sleep Disorder
(20 Jul 2007)
Scientists at deCODE genetics in collaboration with colleagues from Emory University report the discovery of the first variant in the sequence of the human genome ever linked to risk of Restless Legs Syndrome (RLS) and Periodic Limb Movements ...
-
deCODE Announces Appointment of Peter Goodfellow to Board of Directors
(15 Sep 2006)
deCODE genetics announced that it has named Dr. Peter Goodfellow to its Board of Directors, effective immediately.Dr. Goodfellow was until recently Senior Vice President for Discovery Research at GlaxoSmithKline, a position he held for the past six ...
-
deCODE Study Links Gene Variant to Risk of Breast Cancer
(22 Jun 2006)
A population-based study by a team of deCODE scientists and colleagues at Iceland's National University Hospital provides a detailed look at the impact of a gene variant on risk of breast cancer. The variant is within a gene called BARD1 ...
-
deCODE Initiates Phase III Trial for DG031 for the Prevention of Heart Attack
(19 May 2006)
Pioneering use of human genetics to target the causative biology
deCODE genetics announced the initiation of patient enrollment in the pivotal Phase III trial for DG031, deCODE's lead developmental compound for the prevention of heart attack.The multicenter Phase III trial will be randomized, double-blind, ...
Additional information
deCODE genetics
Reykjavik, Iceland
Company
|
|
|
|
|
|
Top
